Viral clearance studies prior to Phase I/II and inclusion in IND submissions for AAV product survey

A survey to understand how member companies are performing viral clearance studies prior to Phase I/II and if members are including these studies within investigational new drug (IND) submission for adeno-associated virus (AAV) products.

This document is reserved for the use of BioPhorum members only.

I don't have access to this document

Make a selection below and submit your request. We will get back to you ASAP.

My company would like to become a member

If you're not sure if your company is a member of this Phorum, or if you would like to enquire on behalf of your company about becoming a member, please see our membership page.